The Effect of the COVID-19 Pandemic on Severe Asthma Care in Europe: Will Care Change for Good?

Background: The coronavirus disease 2019 (COVID-19) pandemic has put pressure on healthcare services, forcing the reorganisation of traditional care pathways. We investigated how physicians taking care of severe asthma patients in Europe reorganised care, and how these changes affected patient satisfaction, asthma control and future care.

Methods: In this European-wide cross-sectional study, patient surveys were sent to patients with a physician-diagnosis of severe asthma, and physician surveys to severe asthma specialists between November 2020 and May 2021.

Results: 1101 patients and 268 physicians from 16 European countries contributed to the study. Common physician-reported changes in severe asthma care included use of video/phone consultations (46%), reduced availability of physicians (43%) and change to home-administered biologics (38%). Change to phone/video consultations was reported in 45% of patients, of whom 79% were satisfied or very satisfied with this change. Of 709 patients on biologics, 24% experienced changes in biologic care, of whom 92% were changed to home-administered biologics and of these 62% were satisfied or very satisfied with this change. Only 2% reported worsening asthma symptoms associated with changes in biologic care. Many physicians expect continued implementation of video/phone consultations (41%) and home administration of biologics (52%).

Conclusions: Change to video/phone consultations and home administration of biologics was common in severe asthma care during the COVID-19 pandemic and was associated with high satisfaction levels in most but not all cases. Many physicians expect these changes to continue in future severe asthma care, though satisfaction levels may change after the pandemic.

Citing Articles

Benralizumab Outcomes in Patients with Severe Eosinophilic Asthma Treated in Real-Life Settings: Results of the BREEZE Study in 5 Countries From Central Eastern Europe and Baltics.

Mihaltan F, Csoma Z, Pauk N, Iras B, Baukiene J, Teodorescu G J Asthma Allergy. 2025; 18:195-210.

PMID: 39990056 PMC: 11844207. DOI: 10.2147/JAA.S503048.

Systematic literature review of asthma biologic self-administration enhanced by a patient perspective.

Boccaletti S, Alfonso-Cristancho R, Ahmed W, Sergison L, Eze A, Auti P J Allergy Clin Immunol Glob. 2024; 3(4):100334.

PMID: 39380980 PMC: 11459623. DOI: 10.1016/j.jacig.2024.100334.

Asthma Care from Home: Study protocol for an effectiveness-implementation evaluation of a virtually enabled asthma care initiative in children in rural NSW.

Mackle R, Crespo Gonzalez C, Chan M, Hodgins M, Hu N, Angell B PLoS One. 2024; 19(6):e0304711.

PMID: 38870226 PMC: 11175534. DOI: 10.1371/journal.pone.0304711.

The accessibility and quality of health services for diabetes mellitus and chronic respiratory disease patients during Covid-19 in Northern Jordan: A mixed method study.

Al-Bataineh R, Al-Hammouri M, Al-Jaraideh W PLoS One. 2023; 18(11):e0294655.

PMID: 37972036 PMC: 10653463. DOI: 10.1371/journal.pone.0294655.

Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis.

Kroes J, Alfonso-Cristancho R, Bansal A, Berret E, Bieksiene K, Bourdin A ERJ Open Res. 2023; 9(2).

PMID: 37020841 PMC: 10068512. DOI: 10.1183/23120541.00745-2022.

References

Brown W, Odenthal D . The uses of telemedicine to improve asthma control. J Allergy Clin Immunol Pract. 2015; 3(2):300-1. DOI: 10.1016/j.jaip.2014.10.003. View

Sargsyan N, Karunaratne D, Masani A, Howell L, Yousif M . ENT Telephone Clinics During the Coronavirus Pandemic: An Analysis of 400 Telephone Consultations at a District General Hospital. Ear Nose Throat J. 2021; 102(11):733-738. DOI: 10.1177/01455613211028091. View

Israel E, Reddel H . Severe and Difficult-to-Treat Asthma in Adults. N Engl J Med. 2017; 377(10):965-976. DOI: 10.1056/NEJMra1608969. View

Codispoti C, Bandi S, Moy J, Mahdavinia M . Running a virtual allergy division and training program in the time of COVID-19 pandemic. J Allergy Clin Immunol. 2020; 145(5):1357-1359. PMC: 7201123. DOI: 10.1016/j.jaci.2020.03.018. View

Horgan T, Alsabbagh A, McGoldrick D, Bhatia S, Messahel A . Oral and maxillofacial surgery patient satisfaction with telephone consultations during the COVID-19 pandemic. Br J Oral Maxillofac Surg. 2020; 59(3):335-340. PMC: 7446653. DOI: 10.1016/j.bjoms.2020.08.099. View

Chongmelaxme B, Lee S, Dhippayom T, Saokaew S, Chaiyakunapruk N, Dilokthornsakul P . The Effects of Telemedicine on Asthma Control and Patients' Quality of Life in Adults: A Systematic Review and Meta-analysis. J Allergy Clin Immunol Pract. 2018; 7(1):199-216.e11. DOI: 10.1016/j.jaip.2018.07.015. View

Krishna M, Beck S, Gribbin N, Nasser S, Turner P, Hambleton S . The Impact of COVID-19 Pandemic on Adult and Pediatric Allergy & Immunology Services in the UK National Health Service. J Allergy Clin Immunol Pract. 2020; 9(2):709-722.e2. PMC: 7703386. DOI: 10.1016/j.jaip.2020.11.038. View

Snoswell C, Rahja M, Lalor A . A Systematic Review and Meta-Analysis of Change in Health-Related Quality of Life for Interactive Telehealth Interventions for Patients With Asthma. Value Health. 2021; 24(2):291-302. DOI: 10.1016/j.jval.2020.09.006. View

Beaney T, Salman D, Samee T, Mak V . Assessment and management of adults with asthma during the covid-19 pandemic. BMJ. 2020; 369:m2092. DOI: 10.1136/bmj.m2092. View

10.

Gibeon D, Heaney L, Brightling C, Niven R, Mansur A, Chaudhuri R . Dedicated severe asthma services improve health-care use and quality of life. Chest. 2015; 148(4):870-876. DOI: 10.1378/chest.14-3056. View

11.

Persaud Y, Portnoy J . Ten Rules for Implementation of a Telemedicine Program to Care for Patients with Asthma. J Allergy Clin Immunol Pract. 2020; 9(1):13-21. PMC: 7543924. DOI: 10.1016/j.jaip.2020.10.005. View

12.

Wu A, Rehman N, Portnoy J . The Good, the Bad, and the Unknown of Telemedicine in Asthma and Allergy Practice. J Allergy Clin Immunol Pract. 2019; 7(8):2580-2582. DOI: 10.1016/j.jaip.2019.08.017. View

13.

Adams L, Lester S, Hoon E, van der Haak H, Proudman C, Hall C . Patient satisfaction and acceptability with telehealth at specialist medical outpatient clinics during the COVID-19 pandemic in Australia. Intern Med J. 2021; 51(7):1028-1037. PMC: 8444675. DOI: 10.1111/imj.15205. View

14.

Mustafa S, Vadamalai K, Ramsey A . Patient Satisfaction with In-Person, Video, and Telephone Allergy/Immunology Evaluations During the COVID-19 Pandemic. J Allergy Clin Immunol Pract. 2021; 9(5):1858-1863. PMC: 7857059. DOI: 10.1016/j.jaip.2021.01.036. View

15.

Kronenfeld J, Penedo F . Novel Coronavirus (COVID-19): telemedicine and remote care delivery in a time of medical crisis, implementation, and challenges. Transl Behav Med. 2020; 11(2):659-663. PMC: 7681072. DOI: 10.1093/tbm/ibaa105. View

16.

Shaker M, Oppenheimer J, Grayson M, Stukus D, Hartog N, Hsieh E . COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic. J Allergy Clin Immunol Pract. 2020; 8(5):1477-1488.e5. PMC: 7195089. DOI: 10.1016/j.jaip.2020.03.012. View

17.

Efthymiadis A, Hart E, Guy A, Harry R, Mahesan T, Abou Chedid W . Are telephone consultations the future of the NHS? The outcomes and experiences of an NHS urological service in moving to telemedicine. Future Healthc J. 2021; 8(1):e15-e20. PMC: 8004310. DOI: 10.7861/fhj.2020-0076. View

18.

Werner R, Glied S . Covid-Induced Changes in Health Care Delivery - Can They Last?. N Engl J Med. 2021; 385(10):868-870. PMC: 9623875. DOI: 10.1056/NEJMp2110679. View

19.

Djukanovic R, Adcock I, Anderson G, Bel E, Canonica G, Cao H . The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research. Eur Respir J. 2018; 52(5). DOI: 10.1183/13993003.01671-2018. View

20.

Tsao L, Villanueva S, Pines D, Pham M, Choo E, Tang M . Impact of Rapid Transition to Telemedicine-Based Delivery on Allergy/Immunology Care During COVID-19. J Allergy Clin Immunol Pract. 2021; 9(7):2672-2679.e2. PMC: 8061180. DOI: 10.1016/j.jaip.2021.04.018. View